他汀类药物使用与高血清胆固醇水平同原发性开角型青光眼风险的关联
该研究基于3个前瞻性队列共136 782名40岁及以上、无青光眼且接受眼科检查的参与者,分析血清胆固醇水平及他汀使用与原发性开角型青光眼(POAG)发病的关联。结果显示,总血清胆固醇每升高20 mg/dL,POAG风险增加7%(RR 1.07,95%CI 1.02-1.11);自报胆固醇升高史亦与更高POAG风险相关(RR 1.17,95%CI 1.00-1.37);任何他汀使用史与POAG风险降低15%相关(RR 0.85,95%CI 0.73-0.99);使用他汀5年及以上相比从未使用与POAG风险降低21%相关(RR 0.79,95%CI 0.65-0.97)。
要点
- 总血清胆固醇每升高20 mg/dL,POAG风险增加7%(RR 1.07,95%CI 1.02-1.11;P=0.004)。
- 任何他汀使用史与POAG风险降低15%相关(RR 0.85,95%CI 0.73-0.99)。
- 使用他汀5年及以上相比从未使用与POAG风险降低21%相关(RR 0.79,95%CI 0.65-0.97;线性趋势P=0.02)。
核心结论
- 在40岁及以上成人中,较高的血清胆固醇水平与较高的POAG风险相关,而使用他汀5年及以上相比从未使用他汀与较低的POAG风险相关。
研究设计与样本
- 研究使用3个基于人群的队列每两年收集的数据:护士健康研究(N=50 710;2000-2014年随访)、护士健康研究2(N=62 992;1999-2015年)和卫生专业人员随访研究(N=23 080;2000-2014年)。
- 参与者为40岁及以上、无青光眼且报告接受眼科检查者;POAG发病病例经病历审查确认;分析于2019年1月进行。
- 暴露信息为每两年更新的自报胆固醇升高状态、血清胆固醇水平及他汀使用时长;采用Cox比例风险回归模型对汇总数据按队列分层估计多变量校正相对风险(RR)及95%CI。
主要发现
- 3个队列共136 782名参与者(113 702名女性与23 080名男性)中,确认886例POAG新发病例。
- 总血清胆固醇每升高20 mg/dL与POAG风险增加7%相关(RR 1.07,95%CI 1.02-1.11;P=0.004)。
- 任何自报胆固醇升高史与较高的POAG风险相关(RR 1.17,95%CI 1.00-1.37)。
- 任何他汀使用史与POAG风险降低15%相关(RR 0.85,95%CI 0.73-0.99)。
- 使用他汀5年及以上相比从未使用他汀与POAG风险降低21%相关(RR 0.79,95%CI 0.65-0.97;线性趋势P=0.02);该关联在年龄较大者中更为反向(≥65岁:RR 0.70,95%CI 0.56-0.87 vs <65岁:RR 1.05,95%CI 0.68-1.63;交互作用P=0.01)。
关键数值与推荐
- 总血清胆固醇每升高20 mg/dL:RR 1.07(95%CI 1.02-1.11;P=0.004)。
- 任何自报胆固醇升高史:RR 1.17(95%CI 1.00-1.37)。
- 任何他汀使用史:RR 0.85(95%CI 0.73-0.99)。
- 使用他汀5年及以上 vs 从未使用:RR 0.79(95%CI 0.65-0.97;线性趋势P=0.02)。
- 使用他汀5年及以上 vs 从未使用,按年龄分层:≥65岁 RR 0.70(95%CI 0.56-0.87)vs <65岁 RR 1.05(95%CI 0.68-1.63);交互作用P=0.01。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The use of statins (hydroxymethylglutaryl coenzyme A inhibitors) has been associated with a lower risk of primary open-angle glaucoma (POAG); however, results have been conflicting, and little is known about the association between high cholesterol levels and POAG. OBJECTIVE: To assess the association of elevated cholesterol levels and statin use with incident POAG. DESIGN, SETTING, AND PARTICIPANTS: This study used data collected biennially from participants aged 40 years or older who were free of glaucoma and reported eye examinations, within 3 population-based cohorts: the Nurses' Health Study (N = 50 710; followed up from 2000 to 2014), the Nurses' Health Study 2 (N = 62 992; 1999-2015), and the Health Professionals Follow-up Study (N = 23 080; 2000-2014). Incident cases of POAG were confirmed by medical record review. The analyses were performed in January 2019. EXPOSURES: Biennially updated self-reported information on elevated cholesterol level status, serum cholesterol levels, and duration of statin use. MAIN OUTCOMES AND MEASURES: Multivariable-adjusted relative risks (RRs) and 95% CIs were estimated using Cox proportional hazards regression models on pooled data, with stratification by cohort. RESULTS: Among the 136 782 participants in the 3 cohorts (113 702 women and 23 080 men), 886 incident cases of POAG were identified. Every 20-mg/dL increase in total serum cholesterol was associated with a 7% increase in risk of POAG (RR, 1.07 [95% CI, 1.02-1.11]; P = .004). Any self-reported history of elevated cholesterol was also associated with a higher risk of POAG (RR, 1.17 [95% CI, 1.00-1.37]). A history of any statin use was associated with a 15% lower risk of POAG (RR, 0.85 [95% CI, 0.73-0.99]). Use of statins for 5 or more years vs never use of statins was associated with a 21% lower risk of POAG (RR, 0.79 [95% CI, 0.65-0.97]; P = .02 for linear trend). The association between use of statins for 5 or more years vs never use of statins and risk of POAG was more inverse in those who were older (≥65 years: RR, 0.70 [95% CI, 0.56-0.87] vs <65 years: RR, 1.05 [95% CI, 0.68-1.63]; P = .01 for interaction). CONCLUSIONS AND RELEVANCE: Among adults aged 40 years or older, higher serum cholesterol levels were associated with higher risk of POAG, while 5 or more years of statin use compared with never use of statins was associated with a lower risk of POAG.
引用
- Kang JH, Boumenna T, Stein JD, et al. Association of Statin Use and High Serum Cholesterol Levels With Risk of Primary Open-Angle Glaucoma. JAMA Ophthalmol. 2019. PMID: 31046067. doi:10.1001/jamaophthalmol.2019.0900
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。